Dianthus Therapeutics Announces Equity Awards to New Employees
Dianthus Therapeutics granted equity awards under Nasdaq Listing Rule 5635(c)(4) as inducements for three newly hired non-executive employees. The grants include options to purchase a total of 60,000 shares with an exercise price of $89.45 per share.
Tickers: $DNTH